About
Maruho Israel Innovation Fund (Mii) is a groundbreaking venture dedicated to advancing skin therapeutics by facilitating a seamless transition from innovative concepts to market-ready solutions. By integrating cutting-edge research and development with strategic venture capital investments, Mii fosters collaborative partnerships that are essential for tackling the evolving challenges in dermatology. Our commitment to innovation not only accelerates the delivery of transformative therapies but also enhances patient outcomes in skin health. Through a dynamic approach, Mii is positioned at the forefront of dermatological advancements, driving progress in a critical area of healthcare.